Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
:PHR
PHR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.07 - $30.53
Previous CloseN/A
Volume173.69K
Average Volume (3M)391.23K
Market Cap
$1.65B
Enterprise Value$998.12M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.49
Next Earnings
Mar 12, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.47
Shares Outstanding58,124,080
10 Day Avg. Volume399,335
30 Day Avg. Volume391,231
Standard Deviation0.17
R-Squared0.09
Alpha0.00080
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.08
Price to Cash Flow (P/CF)71.50
P/FCF Ratio258.00
Enterprise Value/Market Cap0.60
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.30
Enterprise Value/Ebitda-20.55
Forecast
1Y Price Target
$31.55Price Target Upside10.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Market PositionPhreesia has a strong market position, facilitating more than 150 million visits, or over 10% of patient visits in the U.S., with over 100 pharmaceutical brands including all of the top 10 global pharmaceutical companies as customers.
ProfitabilityMargin expansion is a focus area, indicating potential for improved profitability.
Revenue GrowthPhreesia's new pharmacy-related product aims to drive greater medication adherence, complementing existing offerings and boosting revenue growth opportunities.
Bears Say
Revenue GuidanceRevenue guidance for FY'25 and FY'26 has been reduced, with estimates below previous projections.
Revenue ModerationPhreesia's revenue growth is moderating, with the subscription growth and FY'25 revenue guidance being below estimates.
Stock PerformanceThe stock has underperformed the Russell 2000 by a wide margin since reporting 2Q results.
---
Ownership Overview
6.25% Insiders
38.80% Mutual Funds
0.28% Other Institutional Investors
41.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $17.07 and its highest was $30.53 in the past 12 months.
What is Phreesia’s market cap?
Phreesia’s market cap is $1.65B.
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Mar 12, 2025 which is in 18 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Dec 09, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.237 by -$0.013.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -0.18.
How many shares outstanding does Phreesia have?
Phreesia has 58,124,080 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.237. Following the earnings report the stock price went up 11.604%.
Which hedge fund is a major shareholder of Phreesia?
Currently, no hedge funds are holding shares in PHR
---
Phreesia Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.55 (10.86% Upside)
$31.55 (10.86% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $4.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.11%
12-Months-Change
Fundamentals
Return on Equity
-31.89%
Trailing 12-Months
Asset Growth
0.28%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
PHR Company Deck
---
PHR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance with notable revenue growth and profitability improvements. The company demonstrated positive cash flow metrics and provided a promising outlook for fiscal 2026. Despite minor setbacks from a client wind-down and a slightly adjusted revenue outlook for fiscal 2025, the overall sentiment was positive, driven by strong operational performance and strategic growth plans.Read More>---
PHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
PHR Stock 12 Month Forecast
Average Price Target
$31.55
▲(10.86% Upside)
Technical Analysis
Best Analysts Covering PHR
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
-2.39%
reiterated a buy rating 2 months ago
Copying Anne Samuel's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -2.39% per trade.
---